Urinary glycosaminoglycan patterns in angiosarcoma of the liver.
Glycosaminoglycans extracted from 24-hour urine specimens from patients with hepatic angiosarcoma and from normal/controls were separated as cetylpyridinium complexes into "hyaluronic acid," "chondroitin sulfate," and "heparin" fractions, then further separated and characterized by anion-exchange chromatography and hyaluronidase susceptibility. The chromatographic pattern of the urinary chondroitin sulfate fraction in patients with angiosarcoma of the liver differed from those of controls in that there was a relative increase in the total amount of uronic acid in a hyaluronidase-resistant fraction and a decrease in a fraction susceptible to hyaluronidase digestion. These changes appeared to become more pronounced with advancing disease. Chromatographic patterns and determinations of hyaluronidase susceptibility indicated that the resistant fraction was heparan sulfate and that the susceptible fraction was chondroitin-4-sulfate and/or chondroitin-6-sulfate.
D002809:Chondroitin Sulfates / Q000652:urine; D006025:Glycosaminoglycans / Q000652:urine*; D006394:Hemangiosarcoma / Q000652:urine*; D006493:Heparin / Q000652:urine; D006497:Heparan Sulfate / Q000652:urine; D006801:Humans; D006820:Hyaluronic Acid / Q000652:urine; D006821:Hyaluronoglucosaminidase; D008113:Liver Neoplasms / Q000652:urine*; D008297:Male; D008875:Middle Aged
D002809:Chondroitin Sulfates; D006025:Glycosaminoglycans; D006493:Heparin; D006497:Heparan Sulfate; D006820:Hyaluronic Acid; D006821:Hyaluronoglucosaminidase